Gleneagles Hospital partners with Medtronic to launch Renal Denervation Therapy Centre in Mumbai

February 24, 2026 | Tuesday | News

To strengthen the management of complex and resistant hypertension

Gleneagles Hospital, Parel, Mumbai, has partnered with Medtronic India to launch a specialised Renal Denervation Therapy Centre dedicated to the treatment of resistant hypertension.

This new centre is designed to help patients whose blood pressure remains high despite taking multiple medications. With advanced interventional technology, expert teams, and structured care pathways, the hospital aims to offer comprehensive and long-term blood pressure management.

The facility will provide detailed evaluation, patient counselling, medication optimisation, and access to renal denervation therapy for eligible patients. By combining clinical expertise with modern technology, the centre seeks to improve outcomes and reduce the risk of heart, brain, and kidney complications linked to uncontrolled hypertension.

 

Through this dedicated Renal Denervation Therapy Centre, Gleneagles Hospital aims to strengthen the management of complex and resistant hypertension by offering structured evaluation, coordinated care pathways, and personalised treatment plans. The centre brings together cardiologists, nephrologists, and internal medicine specialists to ensure holistic and long-term management for patients with difficult-to-control blood pressure.

 

Speaking on the partnership, Mandeep Singh Kumar, Managing Director & Vice President, Medtronic India, said, “Resistant hypertension remains a growing and often unrecognised challenge in cardiovascular care, and its rising burden underscores the urgent need to reevaluate how care is delivered. Our partnership with Gleneagles Hospital Mumbai is focused on delivering real-world impact by working closely with its clinical teams to strengthen awareness and to enable a more coordinated, structured approach to its diagnosis and management. This collaboration aims to support improved blood pressure control and better long-term outcomes for patients with complex and resistant hypertension. At Medtronic, our mission is to alleviate pain, restore health, and extend life, and collaborations like this are central to that commitment.”

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy